| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.23 | 0.2 |